Markets

NuScale Power Drops Below Equity Sale Price Amid Dilution Concerns

NuScale Power shares slipped 1.7% to $8.56, trading below its recent equity sale average of $9.69. Dilution concerns and heavy cash burn overshadow nuclear policy gains.

Daniel Marsh · · · 3 min read · 4 views
NuScale Power Drops Below Equity Sale Price Amid Dilution Concerns
Mentioned in this article
BWXT $173.09 +2.08% NNE $17.25 +5.12% OKLO $44.13 +6.31% SMR $8.85 +1.61%

NuScale Power Corporation (NYSE:SMR) saw its shares decline 1.7% to $8.56 during Wednesday's trading session in New York, erasing part of the 9.4% advance recorded on Tuesday. The pullback brings the stock 11.7% below the company's most recent disclosed average equity sale price of approximately $9.69, according to SEC filings.

The Tuesday rally occurred without any company-specific announcements—NuScale's press release page shows no updates since July 1. Instead, the move was tied to broader nuclear policy developments, including news that Washington is preparing a civil nuclear agreement with Saudi Arabia and that four U.S. microreactor developers achieved criticality under federal programs. However, analysts caution that policy catalysts may lift the sector before translating into tangible orders for NuScale.

Equity Dilution Overhang

Investor focus remains on the company's equity financing activities. After March 31, NuScale sold 22.36 million shares for gross proceeds of $216.8 million, representing about 6.5% of its combined interests at the end of March. The sale added cash but diluted existing shareholders' stake in future project value. Preliminary calculations suggest roughly $745.3 million of at-the-market (ATM) capacity may remain, assuming no further issuances. At the current share price of $8.56, that authorization equates to approximately 87 million shares.

The balance sheet provides some offset. NuScale ended March with $1.01 billion in cash and investments and no debt. Adding the net proceeds from the recent sale brings total liquidity to roughly $1.22 billion, before subsequent spending. However, cash needs remain substantial. First-quarter operating cash use totaled $314.7 million, including a $259.9 million payment to strategic partner ENTRA1 Energy. Revenue was just $565,000, while the net loss reached $46.7 million.

Competitive Landscape

In the broader nuclear sector, NuScale was the weakest performer among peers in Wednesday's trading. Oklo Inc. (NYSE:OKLO) rose 0.4% to $44.32, Nano Nuclear Energy Inc. (NASDAQ:NNE) fell 0.2% to $17.26, and BWX Technologies Inc. (NYSE:BWXT) gained 1.0% to $174.82. BWX Technologies, with its diversified supplier business, is not a direct development-stage comparison.

Competition is also advancing on the technical front. By July 4, four private developers achieved zero-power criticality—a milestone proving a controlled chain reaction but generating no commercial electricity. NuScale was not among them. Energy Secretary Chris Wright noted, "For the first time in more than four decades, a new privately developed non-light-water reactor has reached criticality."

Regulatory Position and Outlook

NuScale's key advantage remains its regulatory standing. The Nuclear Regulatory Commission (NRC) has approved its US460 design, based on 77-megawatt modules. The NRC is currently discussing future license applications that could reference this design. CEO John Hopkins stated in May, "We are building the infrastructure that this pivotal moment requires," citing $1 billion in liquidity and plans for up to six gigawatts with the Tennessee Valley Authority through ENTRA1. However, these plans remain pre-operational.

NuScale is scheduled to report second-quarter results on August 5. FactSet consensus expects a loss of 13 cents per share. Analyst price targets range from $6 to $25, reflecting unusually wide outcome risk. Investors will focus on cash use, potential new share sales, and binding customer commitments. Risks remain concentrated in project timing, customer financing, construction costs, and dependence on partners. Further equity sales could dilute existing holders before reactor revenue becomes material.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →